Document 3049 DOCN M94A3049 TI Progressive biological markers of HIV infection depending on different risk groups and CDC stages. DT 9412 AU Fuster M; Martinez C; Cortes M; Cadafalch J; Domingo P; Barrio J; Sambeat MA; Internal Medicine Department, Programa SANT PAUCITRAN, Hospital; de Sant Pau, Barcelona, Spain. SO Int Conf AIDS. 1994 Aug 7-12;10(1):165 (abstract no. PB0088). Unique Identifier : AIDSLINE ICA10/94369526 AB OBJECTIVE: To study the biological parameters of HIV progressive infection depending on different risk groups. METHOD: Different biological parameters (B2-M, neopterine, CD4 linfocites, triglicerides, IgA and ADA) have been studied in a sample of 524 HIV+ patients. From the first blood extraction the patients were divided into four different risk groups: 75 heterosexuals, 107 homosexuals, 220 ex IDU and 122 active IDU. Following the CDC criteria for their classification, 360 pacients belonged to the group II-III, 71 patients were IVc2 and 93 patients were IVc1. The four risk groups were showing similar characteristics on the different stages, only statistical significant differences were found in the IVc2 group which was higher in the group of patients who had been infected by the way they took drugs (IDU).. The data were interrelated depending on the risk group and on the CDC stage. Statistical analyses were performed with the Statgraph Statistical Package. RESULTS: All the different parameters being studied were statistically significant, higher in the 93 patients belonging to the IVc1 group (AIDS), except for the ADA in serum which was higher in the IVc2 patients. Independently from the CDC stage the values for the B2-microglobuline were significatively higher in the group of patients showing an active addiction (p = 0.047); neopterine in the heterosexual group (p = 0.0007); ADA in the group of IDU (p = 0.0000). Neither CD4 linfocites nor triglicerides showed any statisticaly significant differences. When relating these data depending on the CDC stage of infection: B2-microglobuline was significatively higher in the II-III stage in the active IDU group (P = 0.0020) and in the IVc1 stage in the homosexual group. Neopterine was significatively higher in the homosexual group depending both on the II-III stage (p = 0.0464) and in the IVc1 (p = 0.0014). IgA was higher in the II-III stage both in the heterosexual and in the homosexual groups (p = 0.0057) without any significant differencies depending neither on the IVc1 nor on the IVc2. ADA values were higher in the II-III in the active IDU(p = 0.0001) and no statisticaly significant difference as found neither in the group IVc1 nor in the IVc2. CONCLUSION: Among asymptomatic patients the B2-M values are higher if and active IDU addiction is present at the moment, while IgA values were higher in the sexual transmission groups (homo and heterosexual) and ADA was so in the parenteral group of risk. Neopterine was higher in the homosexual group through all the stages. DE beta 2-Microglobulin/METABOLISM Acquired Immunodeficiency Syndrome/CLASSIFICATION/DIAGNOSIS/ TRANSMISSION Biological Markers/*BLOOD Biopterin/ANALOGS & DERIVATIVES/BLOOD Female Homosexuality Human HIV Infections/CLASSIFICATION/*DIAGNOSIS/TRANSMISSION IgA/BLOOD Leukocyte Count Male Risk Factors Substance Abuse, Intravenous/COMPLICATIONS/IMMUNOLOGY Triglycerides/BLOOD T4 Lymphocytes/IMMUNOLOGY MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).